Other congenital malformations of skin

Q17_OTHER_CONGEN_MALFO_SKIN

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — Q82 Cause of death: ICD-10 — Q82 2 out of 7 registries used, show all original rules.	1574
4. Check minimum number of events None	1574
5. Include endpoints None	1574
6. Filter based on genotype QC (FinnGen only)	1574

Control definitions (FinnGen only)

Control exclude: Q17_OTHER_CONGEN_MALFO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: Q8
Name in latin: Aliae malformationes congenitae cutis

NAME	Q17_OTHER_CONGEN_MALFO_SKIN
CONTROL_EXCLUDE	Q17_OTHER_CONGEN_MALFO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	Q82
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	Q82
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Other congenital malformations of skin based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Mastocytosis

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	17324	10148	7145
Only index persons	13543	8120	5423
Unadjusted period prevalence (%)
Whole population	0.25	0.29	0.20
Only index persons	0.26	0.30	0.21
Median age at first event (years)
Whole population	14.42	16.84	10.89
Only index persons	23.76	27.52	18.11

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1574	1052	522
Unadjusted period prevalence (%)	0.32	0.36	0.23
Median age at first event (years)	42.20	39.72	47.20

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1418: Matched controls
14182

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

Q82.58

ICD-10 Finland

Congenital non-neoplastic naevus

494.5

323.0

566

Q82.50

ICD-10 Finland

Naevus flammeus

+∞

251.8

234

Q82.2

ICD-10 Finland

Mastocytosis

2158.0

188.8

179

ZXC12

NOMESCO Finland

Pulse colorlaser

262.6

140.9

142

Q82.51

ICD-10 Finland

Naevus portwine

361.1

130.8

130

QAA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of head or neck

109.1

127.6

138

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

6.8

111.3

311

565

Q82.88

ICD-10 Finland

Other specified congenital malformations of skin

+∞

93.8

Q82.5

ICD-10 Finland

Congenital non-neoplastic naevus

127.4

78.8

ZQX00

NOMESCO Finland

0-4% of the skin

271.3

76.2

Q82.80

ICD-10 Finland

Benign familial pemphigus [Hailey-Hailey]

+∞

71.5

D18.0

ICD-10 Finland

Haemangioma, any site

10.5

54.0

108

110

Q82.0

ICD-10 Finland

Hereditary lymphoedema

+∞

53.5

Q82.82

ICD-10 Finland

Inherited keratosis palmaris et plantaris

+∞

50.3

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

12.1

47.9

QBA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of trunk

+∞

44.0

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

4.2

42.6

174

456

Q82.81

ICD-10 Finland

Keratosis follicularis [Darier-White]

+∞

41.9

Q82.9

ICD-10 Finland

Congenital malformation of skin, unspecified

+∞

38.7

D47.0

ICD-10 Finland

Histiocytic and mast cell tumours of uncertain and unknown behaviour

376.8

37.2

Q82.8

ICD-10 Finland

Other specified congenital malformations of skin

+∞

32.4

9741/3-C42.1

ICD-O-3

Malignant mastocytosis of bone marrow

+∞

30.3

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

3.7

29.4

138

405

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

12.8

26.4

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

8.8

24.2

E0000UV

ATC

1.8

23.3

596

4077

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

5.2

22.8

144

ZXC10

NOMESCO Finland

Use of laser

6.3

22.6

101

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

6.4

22.3

Z2221

NOMESCO Finland

Medical doctor

1.9

22.3

415

2542

D05BB02

ATC

acitretin; oral

5.8

22.1

112

Q82.4

ICD-10 Finland

Ectodermal dysplasia (anhidrotic)

+∞

21.9

QCA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of upper limb

81.4

21.7

C96.2

ICD-10 Finland

Malignant mast cell tumour

+∞

19.8

QDA40

NOMESCO Finland

Laser therapy or photocoagulation of skin of lower limb

31.8

19.3

C01CA24

ATC

epinephrine; parenteral

2.7

18.9

133

516

ZXD10

NOMESCO Finland

Scheduled procedure

1.7

18.4

518

3573

E000001

ATC

1.9

17.4

317

1898

D07AB02

ATC

hydrocortisone butyrate; topical

1.8

16.8

376

2409

Q82.1

ICD-10 Finland

Xeroderma pigmentosum

+∞

16.7

2280A

ICD-9 Finland

Haemangioma and lymphangioma, any site, Haemangioma, any site

91.1

16.6

XQ848

NOMESCO Finland

Dermatological photography

4.5

15.9

132

ZXE00

NOMESCO Finland

One hour or less

1.6

15.6

536

3864

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

2.1

15.6

189

967

Z31.5

ICD-10 Finland

Genetic counselling

2.8

15.2

363

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

15.0

245

1406

Z3231

NOMESCO Finland

Registered nurse

1.7

15.0

367

2404

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

3.5

14.7

204

Q87.21

ICD-10 Finland

Klippel-Trénaunay-Weber syndrome

+∞

14.6

Q82.3

ICD-10 Finland

Incontinentia pigmenti

+∞

14.6

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

14.3

14.6

I89.0

ICD-10 Finland

Lymphoedema, not elsewhere classified

12.7

14.4

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

14.1

456

3212

D07AC01

ATC

betamethasone; topical

1.6

14.1

422

2915

XW000

NOMESCO Finland

Bone marrow biopsy

3.4

13.9

203

D02AE01

ATC

carbamide; topical

2.4

13.6

113

484

Q27.4

ICD-10 Finland

Congenital phlebectasia

75.9

13.6

Q85.00

ICD-10 Finland

Neurofibromatosis, type 1

+∞

13.6

Q82.83

ICD-10 Finland

Congenital dyskeratosis

+∞

13.6

J01DB01

ATC

cefalexin; oral

1.6

13.5

1105

9694

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

3.1

13.4

257

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

2.9

13.3

295

B07.9

ICD-10 Finland

Verruca simplex

3.2

13.2

233

D02AX

ATC

Other emollients and protectives

2.9

13.1

284

QAA99

NOMESCO Finland

Other local destruction of skin of head or neck

15.2

13.1

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

12.2

353

2400

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.5

12.1

382

ZXA00

NOMESCO Finland

Right side

1.7

12.0

306

2009

L82

ICD-10 Finland

Seborrhoeic keratosis

1.9

11.6

175

973

S18

ICPC

Laceration/cut

1.5

11.2

492

3688

22700

ICD-8 Finland

Haemangioma and lymphangioma, Haemangioma

20.2

11.1

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

11.2

11.1

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

7.5

11.0

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

2.5

10.9

377

D07AC13

ATC

mometasone; topical

1.6

10.9

360

2521

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

4.4

10.8

QAE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of head or neck

28.2

10.7

D07XC01

ATC

betamethasone, combinations; topical

1.9

10.4

151

826

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

2.0

10.4

139

739

A02BA02

ATC

ranitidine; systemic

1.7

10.2

216

1338

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

2.5

10.0

324

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

3.6

10.0

121

XQ800

NOMESCO Finland

Prick test

2.0

9.9

125

646

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.8

9.7

170

993

L57.0

ICD-10 Finland

Actinic keratosis

2.2

9.5

433

Q27.3

ICD-10 Finland

Peripheral arteriovenous malformation

17.7

9.4

Q27.88

ICD-10 Finland

Other specified congenital malformation of peripheral vascular system

+∞

9.4

Q85.09

ICD-10 Finland

Unspecified neurofibromatosis

+∞

9.4

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

9.2

267

1801

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.5

9.1

337

2411

R4110

NOMESCO Finland

Physiotherapy

1.5

9.1

310

2175

XQ845

NOMESCO Finland

Dermatoscopy

5.1

9.0

R06AE07

ATC

cetirizine; oral

1.4

8.9

570

4552

QB9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in torso, unspecified

7.5

8.9

I78.9

ICD-10 Finland

Disease of capillaries, unspecified

12.6

8.9

ZXA10

NOMESCO Finland

Bilateral

1.7

8.8

212

1358

D07AA02

ATC

hydrocortisone; topical

1.7

8.8

201

1271

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.7

8.8

184

1137

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

4.9

8.7

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

14.1

8.7

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

8.7

131

727

ZXA05

NOMESCO Finland

Left side

1.6

8.6

266

1824

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

8.6

159

948

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

5.1

8.3

Q85.0

ICD-10 Finland

Neurofibromatosis (nonmalignant)

+∞

8.3

7573E

ICD-9 Finland

Congenital anomalies of the integument, Other specified anomalies of skin[URTICARIA PIGMENTOSA (MASTOCYTOSIS)]

+∞

8.3

Z3226

NOMESCO Finland

Physiotherapist

1.6

8.3

232

1550

L85.9

ICD-10 Finland

Epidermal thickening, unspecified

10.8

8.3

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

3.3

8.3

119

ZXD20

NOMESCO Finland

Day surgery

1.7

8.2

159

960

ZXC50

NOMESCO Finland

Cryotherapy

3.2

8.2

131

N02BE01

ATC

paracetamol; systemic, rectal

1.4

8.2

1076

9718

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.4

8.1

466

3632

QBE00

NOMESCO Finland

Excision of loose skin or fold of skin from trunk

8.2

8.1

QAA10

NOMESCO Finland

Incision of skin of head or neck

11.8

8.1

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.6

8.0

222

E000002

ATC

1.7

7.9

161

987

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

7.0

7.8

Q82

ICD-10 Finland

Other congenital malformations of skin

45.2

7.7

UJF32

NOMESCO Finland

Coloscopy

1.5

7.6

268

1887

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

7.6

154

942

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

7.6

307

2230

D07AD01

ATC

clobetasol; topical

1.6

7.5

181

1163

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

2.4

7.4

261

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.7

7.4

168

1061

D07CC01

ATC

betamethasone and antibiotics; topical

1.7

7.4

160

998

WX110

NOMESCO Finland

Local anesthesy

1.4

7.4

909

8021

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.3

7.4

108

J01AA02

ATC

doxycycline; systemic

1.4

7.3

925

8193

S29

ICPC

Skin symptom/complaint other

1.6

7.3

204

1358

Q87.88

ICD-10 Finland

Other specified congenital malformation syndromes, not elsewhere classified

+∞

7.3

QAE50

NOMESCO Finland

Dermabrasion of superficial lesion of skin of head or neck

+∞

7.3

CBB15

NOMESCO Finland

Resection of herniated fat from eyelid

+∞

7.3

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.7

7.2

147

901

WX002

NOMESCO Finland

Sedation and analgesia

1.6

7.2

206

1381

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

3.4

7.2

100

D23.5

ICD-10 Finland

Benign neoplasm: Skin of trunk

3.4

7.2

100

Z71.8

ICD-10 Finland

Other specified counselling

1.5

7.1

309

2272

D07AB08

ATC

desonide; topical

1.7

7.0

135

812

J01FA10

ATC

azithromycin; systemic

1.3

7.0

789

6836

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

4.0

7.0

127

Kela drug reimbursment

Transplant complication

3.6

6.9

QBA10

NOMESCO Finland

Incision of skin of trunk

4.8

6.8

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

2.0

6.8

450

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

6.7

6.8

N03AX12

ATC

gabapentin; oral

1.6

6.8

166

1073

A02BC05

ATC

esomeprazole; systemic

1.4

6.7

437

3460

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

4.3

6.7

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.4

6.7

449

3573

M25.5

ICD-10 Finland

Pain in joint

1.4

6.6

336

2546

QD9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in lower extremities, unspecified

6.9

6.5

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.9

6.5

538

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

6.4

547

J01DA01

ATC

[U] cefalexin; systemic

1.3

6.4

766

6654

J01FF01

ATC

clindamycin; systemic

1.4

6.4

304

2270

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

3.1

6.3

100

C03CA01

ATC

furosemide; systemic

1.5

6.3

228

1616

L85.1

ICD-10 Finland

Acquired keratosis [keratoderma] palmaris et plantaris

18.1

6.3

9744

FHL

+∞

6.3

Q82.52

ICD-10 Finland

Mongolian blue spot

+∞

6.3

Q82.84

ICD-10 Finland

Pseudoxanthoma elasticum

+∞

6.3

Q82.86

ICD-10 Finland

Gorlins syndrome

+∞

6.3

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.9

6.2

471

M79.6

ICD-10 Finland

Pain in limb

1.4

6.2

406

3210

ICD-10 Finland

3.1

6.1

102

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.0

6.1

409

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.6

6.1

138

873

TQW99

NOMESCO Finland

Other minor procedure on skin

2.3

6.1

249

TQW80

NOMESCO Finland

Local dermatologic skincare

2.7

6.1

137

J02AC01

ATC

fluconazole; systemic

1.3

6.1

490

4003

L04AA06

ATC

mycophenolic acid; systemic

3.4

6.1

R06AX27

ATC

desloratadine; oral

1.4

6.0

374

2929

XA800

NOMESCO Finland

Neuropsychological investigation

2.1

6.0

298

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768443) Skin Pathology biopsy report

122

459

2.80

23.18

1.3

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

228

1156

2.14

22.43

6.1

4.2

u/l

212.0

256.7

3.82

221

1100

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

717

5230

1.68

21.91

2.8

2.4

nmol/l

75.6

75.1

0.20

667

4781

(3045142) Bone marrow Pathology biopsy report

126

4.40

21.43

1.5

1.4

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

168

3.80

20.15

1.6

1.7

—

(3019198) Lymphocytes [#/volume] in Blood

867

6744

1.64

19.86

7.5

6.1

e9/l

2.0

0.22

797

5992

(40768804) Tissue Pathology biopsy report

668

4882

1.64

19.58

2.3

2.0

—

(3001604) Monocytes [#/volume] in Blood

842

6522

1.63

19.45

7.5

6.1

e9/l

0.5

0.6

1.48

756

5672

(3006315) Basophils [#/volume] in Blood

844

6545

1.62

19.38

7.5

6.1

e9/l

0.0

0.95

760

5697

(3013115) Eosinophils [#/volume] in Blood

864

6754

1.62

19.07

7.8

6.4

e9/l

0.2

0.12

787

5979

(3013650) Neutrophils [#/volume] in Blood by Automated count

938

7491

1.62

18.88

9.8

9.0

e9/l

4.0

0.07

849

6561

(42870588) Differential panel, method unspecified - Blood

601

4359

1.61

17.66

7.4

6.2

—

(3018418) pH of Serum or Plasma

480

3297

1.66

17.54

4.5

3.8

7.4

0.03

642

(3024561) Albumin [Mass/volume] in Serum or Plasma

660

4918

1.59

17.19

5.4

4.9

g/l

36.4

36.3

0.18

618

4592

(3018010) Neutrophils/100 leukocytes in Blood

808

6311

1.58

17.16

7.4

6.0

55.8

0.01

779

5948

(3002030) Lymphocytes/100 leukocytes in Blood

814

6399

1.56

16.58

7.6

6.2

29.7

29.6

0.08

785

6009

(3022096) Basophils/100 leukocytes in Blood

763

5940

1.55

16.03

7.7

6.3

0.6

0.7

0.68

735

5576

(3006504) Eosinophils/100 leukocytes in Blood

784

6142

1.55

16.00

7.7

6.2

2.8

0.16

754

5747

(3019069) Monocytes/100 leukocytes in Blood

788

6181

1.55

15.99

7.9

6.4

8.1

8.4

1.71

760

5827

(3005322) IgE [Units/volume] in Serum or Plasma

186

990

2.00

15.83

1.5

1.3

u/ml

146.5

222.0

1.18

169

920

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

737

5758

1.53

14.82

7.9

7.2

mmol/l

1.2

0.35

651

4890

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1084

9278

1.54

13.64

8.1

7.0

u/l

80.4

79.3

0.30

1040

8732

(3033658) Prothrombin time (PT) actual/Normal

429

3052

1.56

12.84

4.7

4.1

91.6

92.6

0.38

418

2966

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

669

5243

1.48

12.56

7.4

6.7

mmol/l

1.2

0.14

627

4775

(3044889) 12 lead EKG panel

962

8149

1.46

11.77

3.6

3.4

—

(3027945) Reticulocytes/100 erythrocytes in Blood

202

1212

1.76

11.72

3.1

3.5

1.6

1.8

0.97

189

1089

(40758558) Short blood count panel - Blood

453

3330

1.51

11.43

7.2

6.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

398

2853

1.53

11.29

2.0

1.9

mg/l

1.2

1.1

0.11

306

2115

(21494434) Karyotype in Bone marrow

102

3.59

11.05

1.4

1.3

—

(3002385) Erythrocyte distribution width [Ratio]

1246

11242

1.52

10.11

18.7

15.0

13.7

13.5

1.57

1230

11014

(3000494) Fungus identified in Specimen by Culture

222

1425

1.65

10.00

1.8

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

218

1394

1.65

9.97

2.9

3.2

umol/l

7.1

7.3

0.06

187

1187

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

4.82

9.55

2.8

3.3

ug/l

83.3

107.5

0.31

(3004789) Transferrin [Mass/volume] in Serum or Plasma

245

1632

1.59

9.47

2.3

2.4

g/l

2.4

0.07

228

1507

(3013707) Erythrocyte sedimentation rate by Westergren method

1056

9279

1.42

9.39

4.4

3.9

mm/h

10.8

0.04

1014

8623

(40768797) Stomach Pathology biopsy report

246

1647

1.59

9.30

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

228

1500

1.61

9.28

2.1

1.6

—

(3022948) Iron [Moles/volume] in Serum or Plasma

263

1796

1.56

9.11

2.4

umol/l

13.1

13.8

0.90

248

1657

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

227

1505

1.59

8.93

2.5

21.8

23.4

0.74

190

1306

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

737

6134

1.38

8.83

6.3

6.0

umol/l

10.8

12.0

1.91

704

5781

(3002256) Pathology report gross observation

223

1481

1.59

8.70

1.4

1.2

—

(3021589) Normoblasts [#/volume] in Blood

707

5876

1.37

8.40

10.4

9.0

e9/l

0.0

0.28

589

4787

(3015377) Calcium [Moles/volume] in Serum or Plasma

500

3937

1.40

8.24

3.2

3.3

mmol/l

2.4

0.22

441

3495

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

286

2031

1.50

8.21

3.3

3.5

ng/l

431.1

489.8

0.10

187

1409

(3030467) Casts [#/volume] in Urine by Automated count

431

3318

1.41

8.07

3.5

3.0

e6/l

0.3

0.4

0.25

325

2481

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

429

3307

1.41

7.95

2.3

2.2

u/l

492.4

231.5

0.80

412

3122

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

424

2.01

7.94

1.5

2.2

g/l

1.3

1.5

0.60

373

(3012095) Magnesium [Moles/volume] in Serum or Plasma

264

1865

1.50

7.75

4.9

4.3

mmol/l

0.8

0.67

245

1742

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

403

3086

1.41

7.73

2.5

2.2

mg/l

2.8

2.9

0.42

349

2647

(36304419) Bacteria [Presence] in Urine

422

3281

1.39

7.35

3.5

3.0

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

231

1605

1.51

7.32

6.7

6.5

mmol/l

1.1

0.75

220

1498

(40760892) CBC W Ordered Manual Differential panel - Blood

388

2977

1.40

7.30

5.2

4.5

—

(3023520) Reticulocytes [#/volume] in Blood

139

864

1.67

7.07

2.8

3.1

e9/l

69.2

71.3

0.30

107

632

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

274

1993

1.45

6.90

3.0

2.7

e6/l

1.4

1.1

0.28

155

1112

(3003338) MCHC [Mass/volume]

1252

11559

1.41

6.79

20.3

15.5

g/l

332.3

332.9

1.46

1244

11474

(3000850) Epithelial cells [#/volume] in Urine

330

2490

1.41

6.79

2.8

2.5

e6/l

10.6

7.2

0.28

292

2203

(3001122) Ferritin [Mass/volume] in Serum or Plasma

720

6150

1.31

6.54

3.3

2.8

ug/l

103.0

97.4

0.23

680

5746

(3002582) Erythrocytes [#/volume] in Urine

452

3628

1.35

6.29

3.6

3.2

e6/l

38.9

75.4

0.90

343

2766

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

548

4524

1.32

6.29

2.1

1.8

pmol/l

95.5

96.2

0.15

281

2377

(3044290) Cell count panel - Cerebral spinal fluid

291

2.07

6.27

1.7

2.0

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

186

1275

1.52

6.27

2.1

1.8

—

(3018095) Leukocytes [#/volume] in Urine

535

4405

1.33

6.24

4.3

3.6

e6/l

76.0

70.1

0.10

376

2990

(3018677) aPTT in Platelet poor plasma by Coagulation assay

243

1761

1.45

6.21

2.3

2.5

29.4

29.7

0.29

237

1711

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

246

1792

1.44

6.11

2.3

1.8

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

267

1980

1.42

6.01

3.2

2.7

mmol/l

2.4

0.22

231

1736

(3000991) Gas panel - Venous blood

156

1040

1.56

5.97

9.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

382

3016

1.35

5.87

1.5

g/l

2.3

2.2

0.36

223

1821

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1117

10212

1.32

5.83

4.5

4.0

pmol/l

14.4

14.6

2.67

1041

9373

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

166

1130

1.52

5.78

2.7

2.3

u/l

29.2

81.2

0.64

146

944

(3036481) Cortisol [Moles/volume] in Serum or Plasma

180

1247

1.50

5.77

2.3

2.2

nmol/l

358.8

372.3

0.39

169

1160

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

182

1264

1.50

5.76

2.1

1.8

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

317

1.96

5.64

1.9

2.0

e6/l

3169.2

760.1

0.43

245

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

317

1.96

5.64

1.8

2.0

e6/l

47.0

8.7

0.74

236

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1376

13025

1.45

5.57

15.5

12.3

mg/l

19.5

21.8

2.25

1098

10079

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

134

2.49

5.55

1.5

1.4

pmol/l

446.6

417.4

0.08

104

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1274

11911

1.37

5.48

5.4

4.7

mu/l

1.9

2.1

0.58

1210

11052

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

3.36

5.45

1.1

g/l

0.3

0.55

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

252

1883

1.40

5.41

3.0

2.9

e6/l

4.0

2.8

0.45

132

1005

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

427

3464

1.32

5.39

1.4

1.3

u/ml

1.0

1.8

1.70

905

(3042936) Bacteria identified in Isolate by Culture

226

1666

1.42

5.24

2.1

2.0

—

(3023368) Bacteria identified in Blood by Culture

365

2915

1.33

5.12

5.0

4.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

13.39

5.08

1.0

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

799

7066

1.27

5.03

5.9

4.8

mmol/l

6.4

6.5

0.61

741

6515

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

339

1.86

4.97

1.8

2.4

g/l

10.6

10.4

0.11

293

(3020779) Urea [Moles/volume] in Serum or Plasma

146

1004

1.50

4.86

8.5

8.7

mmol/l

8.4

8.1

0.16

141

966

(3036489) Thrombin time

515

1.69

4.83

2.9

3.0

21.6

21.2

0.28

464

(3009542) Hematocrit [Volume Fraction] of Blood

1315

12425

1.36

4.72

17.2

13.1

39.9

0.02

1052

9612

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

115

758

1.56

4.66

2.9

3.1

ng/l

129.8

178.2

1.27

102

686

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

120

800

1.54

4.63

2.4

2.3

ug/l

6.7

7.1

0.10

110

714

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

179

2.15

4.62

1.2

1.3

—

(3017400) Magnesium [Moles/volume] in Urine

14.05

4.58

1.0

—

2.9

—

(3020630) Protein [Mass/volume] in Serum or Plasma

121

812

1.53

4.53

2.0

3.0

g/l

67.4

66.7

0.45

111

749

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

365

1.79

4.51

1.9

2.4

g/l

7.0

7.4

1.08

285

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

365

1.79

4.51

1.9

2.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

292

1.88

4.51

1.9

3.9

mg/l

39.5

71.3

0.80

239

(3026493) Urate [Moles/volume] in Serum or Plasma

358

2898

1.30

4.50

3.0

2.6

umol/l

4276.8

4776.0

0.09

328

2544

(3031040) Bacteria [#/volume] in Urine by Automated count

926

8393

1.25

4.49

4.9

4.2

e6/l

1188.8

2305.4

0.49

109

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

496

4191

1.27

4.44

3.4

3.3

u/l

29.4

31.3

0.89

462

3989

(3019550) Sodium [Moles/volume] in Serum or Plasma

1353

12871

1.37

4.40

17.0

13.6

mmol/l

139.6

0.14

1331

12515

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

346

1.79

4.38

1.9

2.4

g/l

3.1

0.01

276

(3026782) Osmolality of Urine

295

2338

1.32

4.31

2.8

2.7

mosm/kgh2o

557.7

546.3

0.38

253

2024

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1419

13615

1.43

4.30

11.4

9.5

u/l

26.1

0.01

1391

13180

(36660697) Celiac disease serology panel - Serum

169

1228

1.42

4.25

1.2

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

365

1.76

4.23

1.9

2.4

g/l

3.7

0.04

272

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

669

5875

1.24

4.22

4.0

—

(3021960) Folate [Moles/volume] in Serum or Plasma

317

2546

1.31

4.20

1.6

1.5

nmol/l

20.5

20.7

0.09

285

2188

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

292

1.84

4.20

1.9

4.0

mg/l

26.1

45.1

1.03

239

(3023103) Potassium [Moles/volume] in Serum or Plasma

1354

12902

1.36

4.18

17.1

13.6

mmol/l

3.9

1.21

1329

12515

(3014576) Chloride [Moles/volume] in Serum or Plasma

179

1324

1.40

4.07

9.6

7.2

mmol/l

105.2

104.4

1.68

174

1294

(3011397) Hemoglobin [Presence] in Urine by Test strip

358

2934

1.29

4.06

3.9

3.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

149

2.17

4.04

1.2

1.3

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

218

1.95

3.99

1.4

1.7

g/l

0.7

0.8

0.28

168

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1166

10928

1.26

3.85

5.2

5.0

mmol/mol

38.3

38.8

1.16

1113

10203

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

395

3307

1.26

3.73

1.8

1.7

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

122

2.23

3.68

1.1

1.2

u/l

59.1

62.3

0.09

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

268

1.82

3.68

11.1

6.7

iu/ml

672.4

276.4

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1231

11635

1.27

3.64

3.9

3.6

mmol/l

1.3

0.28

1161

10806

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

279

2244

1.30

3.64

1.3

1.2

iu/ml

56.3

31.5

0.78

688

(3018133) Calcium [Moles/volume] in Urine

2.88

3.63

1.4

3.2

mmol/l

2.4

2.6

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

493

1.59

3.59

1.2

u/ml

0.4

0.9

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

287

1.77

3.51

1.1

u/ml

20.9

6.2

0.71

125

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

159

2.03

3.46

1.1

1.3

nmol/l

0.5

0.6

0.42

151

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1059

9872

1.22

3.42

3.6

3.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

233

1845

1.31

3.41

1.7

nmol/l

1153.6

1203.1

0.32

166

1403

(3003327) Ova and parasites identified in Stool by Light microscopy

502

1.56

3.35

1.8

1.7

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

125

902

1.42

3.31

2.2

2.4

au/ml

40.7

20.9

—

(3004588) Protein electrophoresis panel - Serum or Plasma

659

1.49

3.30

1.8

2.5

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1246

11836

1.25

3.27

4.3

4.0

mmol/l

5.7

5.8

1.00

1156

10890

(3023323) Follitropin [Units/volume] in Serum or Plasma

112

796

1.44

3.23

1.5

iu/l

25.1

25.0

0.01

663

(3048929) Epstein Barr virus Ab [Presence] in Serum

622

1.49

3.20

1.4

—

(3010813) Leukocytes [#/volume] in Blood

1503

14675

1.54

3.18

22.5

18.0

e9/l

6.8

6.7

0.66

1474

14287

(4035726)

133

978

1.39

3.17

1.4

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

130

953

1.40

3.15

10.5

9.1

g/l

120.8

122.1

0.28

125

921

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

328

2738

1.25

3.14

2.9

3.0

ng/l

1463.0

1110.1

0.58

284

2286

(3024731) MCV [Entitic volume]

1502

14667

1.53

3.13

22.4

17.9

90.1

0.04

1493

14482

(3026361) Erythrocytes [#/volume] in Blood

1502

14671

1.53

3.08

22.5

17.9

e12/l

4.5

0.40

1471

14287

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

132

2.06

3.07

2.5

1.9

—

(4062490)

139

2.03

3.06

1.3

—

(3000963) Hemoglobin [Mass/volume] in Blood

1502

14679

1.51

2.98

22.6

18.1

g/l

134.7

135.2

0.80

1492

14488

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

616

1.47

2.96

1.7

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

257

1.73

2.96

1.1

u/ml

7.6

6.5

0.17

125

(3002032) Base excess in Venous blood by calculation

153

1166

1.35

2.93

5.7

5.6

mmol/l

1.2

1.7

0.80

132

929

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

152

1160

1.34

2.89

9.4

8.4

kpa

5.0

5.1

0.71

144

1106

(3027801) Oxygen [Partial pressure] in Arterial blood

152

1160

1.34

2.89

9.4

8.4

kpa

12.5

12.6

0.09

143

1111

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

143

1.98

2.86

1.1

1.2

nmol/l

—

(3016502) Oxygen saturation in Arterial blood

136

1024

1.36

2.83

9.9

9.0

96.7

95.6

1.75

131

987

(3026389) Candida sp identified in Specimen by Organism specific culture

172

1.88

2.82

1.8

1.3

—

(3016018) Differential panel - Cerebral spinal fluid

151

1.94

2.81

2.2

2.3

—

(3035941) MCH [Entitic mass]

1500

14670

1.48

2.79

22.4

17.9

30.0

30.1

0.24

1491

14483

(3003396) Base excess in Arterial blood by calculation

151

1158

1.34

2.79

9.5

8.4

mmol/l

0.4

1.1

1.07

118

899

(3007461) Platelets [#/volume] in Blood

1499

14659

1.48

2.78

22.6

18.0

e9/l

259.2

257.5

0.45

1475

14309

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

101

1382

0.71

2.78

3.6

4.0

32.8

32.2

0.24

963

(3025159) Blasts/100 leukocytes in Blood

123

914

1.38

2.78

5.0

4.4

0.1

0.5

0.54

218

(3022145) Colonoscopy Study observation

169

1319

1.32

2.76

1.3

—

(3044640) Blood type and Crossmatch panel - Blood

443

3861

1.21

2.76

2.5

2.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

135

1021

1.35

2.73

2.7

2.9

g/l

10.1

10.3

0.21

130

945

(40760888) Immunoglobulin light chains.free panel - Serum

219

1.75

2.70

1.6

4.3

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

116

859

1.38

2.69

3.5

3.4

pmol/l

4.8

4.6

0.25

108

768

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

538

1.47

2.67

13.3

9.9

mmol/l

23.7

24.3

0.83

505

(3021440) Promyelocytes/100 leukocytes in Blood

127

957

1.36

2.64

5.2

4.3

0.1

0.12

255

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

298

1.63

2.61

1.5

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

230

1882

1.26

2.61

2.5

2.4

ug/g

93.4

118.6

0.95

192

1485

(3021879) Hepatitis B virus core Ab [Presence] in Serum

151

1170

1.32

2.61

1.4

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

192

1.79

2.59

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1284

12320

1.23

2.59

4.7

4.3

mmol/l

2.8

0.61

1216

11463

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

668

1.42

2.58

1.7

1.5

—

(4010399)

112

832

1.37

2.55

1.6

1.4

—

(3035350) Ketones [Presence] in Urine by Test strip

693

6316

1.17

2.54

3.8

3.4

estimate

0.0

0.00

121

1217

(3037522) Nuclear Ab [Titer] in Serum

222

1816

1.26

2.53

1.4

1.3

titre

531.1

508.7

0.05

344

(3026008) Bacteria identified in Urine by Culture

414

3613

1.20

2.52

3.3

2.7

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

136

1.93

2.51

1.3

g/l

6.3

6.8

0.46

101

(3028192) IgG subclass 2 [Mass/volume] in Serum

136

1.93

2.51

1.3

g/l

3.3

2.7

1.32

(3024139) IgG subclass 3 [Mass/volume] in Serum

136

1.93

2.51

1.3

g/l

0.4

0.36

100

(3017181) Myelocytes/100 leukocytes in Blood

132

1010

1.34

2.50

5.2

4.2

0.7

0.9

0.57

281

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1262

12101

1.22

2.49

4.1

3.9

mmol/l

1.5

0.46

1193

11272

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

116

871

1.36

2.48

1.1

1.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

547

1.45

2.47

13.2

11.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1268

12168

1.22

2.46

4.4

4.0

mmol/l

4.7

1.15

1211

11394

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

2.68

2.45

1.3

1.1

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.68

2.45

1.7

—

(3011897) Casein IgE Ab [Units/volume] in Serum

2.47

2.45

1.7

u/ml

0.9

8.4

—

(3009508) Creatinine [Moles/volume] in Urine

409

3576

1.19

2.43

3.1

3.4

mmol/l

8.4

7.7

1.83

365

3067

(3025130) Human papilloma virus identified in Specimen

204

1.73

2.42

1.7

1.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

345

1.55

2.40

1.4

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

2.36

2.39

1.0

1.2

u/l

30.4

24.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

2.36

2.39

1.0

1.2

u/l

115.6

86.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

425

3738

1.19

2.36

2.6

2.4

u/l

51.6

56.8

3.07

396

3455

(3032080) INR in Blood by Coagulation assay

480

4266

1.18

2.36

8.3

7.5

inr

1.1

1.2

0.38

143

1298

(3021601) Nitrite [Presence] in Urine by Test strip

693

6345

1.16

2.34

5.2

4.6

estimate

0.0

0.50

129

1250

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1218

11661

1.20

2.33

13.5

10.8

ml/min/173m2

88.6

87.5

0.90

1005

9388

(3002179) Metamyelocytes/100 leukocytes in Blood

122

933

1.33

2.33

5.1

4.0

0.6

0.5

0.15

207

(3000012) Reticulocyte production index

2.39

2.29

1.7

1.9

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

659

1.39

2.27

1.1

—

1.0

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

253

2127

1.23

2.26

1.2

u/ml

5.0

11.6

1.67

846

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

186

1.74

2.25

1.7

1.6

—

(3035637) Corticotropin [Mass/volume] in Plasma

179

1.75

2.23

1.5

1.6

—

(3037467) Urinalysis macro (dipstick) panel - Urine

936

8790

1.16

2.21

4.7

4.1

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

242

1.63

2.17

1.1

u/ml

0.2

0.5

0.93

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

4.30

2.15

1.0

1.3

umol/24h

1.4

1.7

—

(3012501) Base excess in Blood by calculation

235

1.63

2.15

3.6

3.3

mmol/l

3.4

2.3

1.34

148

(3014765) Yersinia sp identified in Stool by Organism specific culture

396

1.48

2.14

1.1

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

267

1.59

2.13

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

267

1.59

2.13

1.4

1.3

—

(3019150) Specific gravity of Urine by Refractometry

325

2820

1.19

2.09

4.0

3.7

kg/l

1.0

0.03

405

(3003181) Sodium [Moles/volume] in Urine

199

1.67

2.06

1.4

1.6

mmol/l

97.9

66.6

1.81

170

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

920

8653

1.15

2.05

3.1

u/l

47.2

42.0

0.81

871

8175

(46235355) HIV 1 and 2 tests - Meaningful Use set

377

3322

1.18

2.02

2.0

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

105

805

1.33

2.00

2.2

2.1

nmol/l

11.6

12.3

0.37

716

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

328

1.51

2.00

1.4

u/ml

222.9

241.8

0.23

197

(40761535) Cells panel - Urine sediment

118

920

1.31

2.00

4.1

3.4

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

232

1.61

2.00

1.1

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.15

1.98

1.1

2.0

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.15

1.98

1.1

2.0

—

(3009261) Glucose [Presence] in Urine by Test strip

694

6411

1.15

1.98

3.8

3.4

estimate

0.0

0.36

129

1205

(3013139) Helicobacter pylori Ag [Presence] in Stool

109

844

1.31

1.95

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

134

1068

1.28

1.93

1.2

iu/ml

108.0

146.7

0.75

420

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

106

1.90

1.91

2.5

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

220

1.60

1.89

2.7

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

113

887

1.30

1.84

3.6

4.4

ng/l

80.1

75.7

0.25

101

798

(42529406) Shigella sp [Presence] in Stool by Culture

402

1.43

1.82

1.1

1.2

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

668

1.34

1.82

1.8

1.6

mu/l

336.4

312.5

0.31

597

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

394

1.44

1.81

1.1

1.2

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.10

1.76

2.4

1.9

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

229

1957

1.20

1.75

3.8

4.0

24.6

21.1

1.92

856

(3015076) Soybean IgE Ab [Units/volume] in Serum

117

1.81

1.74

1.0

1.1

u/ml

0.5

4.4

—

(1616796) Gas panel - Central venous blood

233

1.56

1.74

4.2

3.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.51

1.74

3.7

7.2

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

415

1.41

1.73

1.1

1.2

u/ml

1.7

2.0

0.10

206

(40761511) CBC panel - Blood by Automated count

1403

13699

1.22

1.72

12.9

11.3

—

(40758292) HTLV I+II Ab panel - Serum

2.92

1.72

1.1

1.5

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

266

1.52

1.72

1.2

1.7

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

365

1.44

1.72

1.1

u/ml

0.9

3.2

2.23

106

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

316

1.47

1.70

1.7

2.3

mg/l

9.2

11.3

1.30

293

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

366

1.44

1.70

1.6

1.7

nmol/l

41.7

39.9

0.16

354

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

301

1.48

1.66

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

107

847

1.28

1.66

2.9

2.3

u/l

1902.4

4996.4

1.68

333

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.81

1.65

1.1

4.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.81

1.65

1.6

1.4

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

306

2698

1.17

1.63

1.6

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

137

1121

1.24

1.62

2.3

2.6

g/l

0.2

0.51

128

1056

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

3.58

1.61

2.4

1.6

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.15

1.61

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.15

1.61

1.1

85.8

90.1

0.22

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.15

1.61

1.2

1.0

68.8

89.8

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

279

1.48

1.60

1.6

u/ml

126.5

98.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

129

1.72

1.57

2.8

1.6

—

(3023410) Appearance of Cerebral spinal fluid

168

1.62

1.55

2.2

2.4

—

(3000492) Spirometry study

150

1247

1.22

1.54

1.7

1.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

143

1183

1.23

1.54

23.9

20.9

inr

1.3

1.2

0.43

166

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

315

1.44

1.54

2.6

1.6

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

130

1.70

1.53

1.8

2.2

32.1

32.2

0.01

130

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

1.52

0.0

1.4

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.86

1.50

1.3

2.0

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

514

1.34

1.49

1.6

2.1

u/l

36.2

38.6

0.48

464

(3030313) Adrenal Ab [Titer] in Serum

3.13

1.44

1.0

1.1

—

(3048879) Bone marrow aspiration report

2.73

1.43

2.7

2.1

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

211

1825

1.18

1.43

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

278

1.45

1.43

1.4

1.3

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

149

1.62

1.41

2.1

1.8

—

(3034426) Prothrombin time (PT)

2.18

1.40

1.1

1.3

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

230

1.49

1.39

1.3

1.2

u/ml

1.3

4.1

—

(40765096) Chromosome analysis panel by Banding

2.42

1.39

1.0

1.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

1.95

1.38

1.2

1.4

—

248.3

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.13

1.33

1.3

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

613

1.29

1.32

2.1

1.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

429

1.34

1.31

1.4

1.3

—

(3024928) Oxygen saturation in Venous blood

250

1.45

1.31

8.7

6.0

—

(3019060) Gas panel - Arterial blood

651

1.27

1.29

4.5

6.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

226

1.47

1.29

1.3

1.2

u/ml

3.4

5.0

0.51

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

1.89

1.28

1.2

1.4

u/l

5.1

7.0

0.81

(3032352) Blasts [#/volume] in Cerebral spinal fluid

2.78

1.28

3.2

5.5

—

(3000093) Morphology [Interpretation] in Blood Narrative

114

1.67

1.28

1.5

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.73

1.27

2.8

2.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.79

1.27

1.3

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

287

2568

1.14

1.26

1.5

1.4

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

320

1.39

1.26

1.3

1.2

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

415

1.34

1.26

1.2

1.1

—

(3000475) Leukocytes [#/volume] in Synovial fluid

261

1.43

1.25

1.6

1.7

e6/l

11217.8

14942.6

0.30

195

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

312

1.39

1.25

2.7

1.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

2.23

1.24

1.1

—

(4027681)

100

1.71

1.23

1.1

1.2

—

(3024263) Appearance of Synovial fluid

2.05

1.22

1.8

1.7

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

2.64

1.21

1.0

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

124

1.62

1.21

1.1

1.5

u/ml

0.0

0.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

109

904

1.22

1.19

3.2

3.5

mmol/l

1.2

1.40

786

(3008401) Mugwort IgE Ab [Units/volume] in Serum

367

1.35

1.19

1.1

u/ml

0.9

1.3

0.31

190

(3024354) Oxygen [Partial pressure] in Venous blood

121

1015

1.21

1.18

5.6

5.3

kpa

5.1

4.8

0.59

121

982

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.94

1.17

1.9

1.3

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.01

1.16

1.3

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

197

1727

1.16

1.7

1.8

1.4

0.42

179

1556

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

110

1.64

1.15

2.7

2.5

15.1

11.0

0.49

(3010144) Erythrocytes [#/volume] in Synovial fluid

110

1.64

1.15

1.1

1.4

e6/l

81538.9

101085.2

0.08

(3008536) Aspergillus sp Ab [Presence] in Serum

2.50

1.15

6.0

1.4

—

(3037756) Immunofixation for Serum or Plasma

200

1.46

1.12

1.3

1.7

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

159

1.52

1.12

2.7

1.5

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.90

1.12

1.9

1.3

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

792

1.23

1.12

2.0

1.7

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

217

1.44

1.11

1.2

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

274

2468

1.13

1.10

3.9

4.5

ug/l

1.8

2.2

0.92

254

2226

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

559

0.74

1.10

1.5

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

177

1547

1.16

1.09

1.8

—

(3020682) Albumin/Creatinine [Ratio] in Urine

344

3144

1.12

1.09

4.0

mg/mmol

6.1

14.1

0.78

241

1999

(3011412) CD3 cells [#/volume] in Blood

136

1.55

1.08

5.1

2.5

e9/l

1.1

1.4

1.00

(44790049)

178

1.47

1.05

2.1

1.6

—

(44790047)

178

1.47

1.05

2.1

1.6

—

(44790048)

178

1.47

1.05

2.1

1.6

—

(44806118)

178

1.47

1.05

2.1

1.6

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.71

1.05

1.1

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

227

2027

1.14

1.05

1.5

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

171

1497

1.16

1.04

1.9

2.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

581

1.25

1.04

1.2

1.3

miu/ml

190.9

234.9

0.44

297

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.28

1.03

1.6

—

(3012516) Albumin [Mass/volume] in Urine

328

3001

1.12

1.02

3.3

mg/l

924.4

347.5

0.81

226

1915

(1761868) Lipid panel - Serum or Plasma

500

4680

1.10

1.01

2.6

2.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

458

1.28

1.00

1.6

1.3

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.88

1.00

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

561

0.76

1.00

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

561

0.76

1.00

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

561

0.76

1.00

1.5

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

140

1212

1.17

0.99

1.8

1.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

540

1.25

0.98

2.6

2.3

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.18

0.98

1.2

3.1

—

2.6

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

487

1.26

0.97

1.4

1.3

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

224

1.39

0.97

1.2

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

1.74

0.96

2.6

2.5

e6/l

121.7

370.0

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

0.00

0.96

0.0

7.5

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

578

1.24

0.96

2.6

2.7

e6/l

0.2

0.12

554

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

157

1.47

0.96

1.8

1.5

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

0.00

0.95

0.0

7.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

242

1.37

0.95

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

141

1.50

0.95

1.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

294

1.33

0.95

1.8

—

(40767503) Oxygen content in Capillary blood by calculation

225

1.39

0.95

3.1

2.4

17.0

16.5

0.29

119

(3003888) Timothy IgE Ab [Units/volume] in Serum

382

1.29

0.94

1.1

u/ml

3.9

5.6

0.36

235

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

1.90

0.94

4.6

5.4

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

1.90

0.94

2.3

2.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

312

1.32

0.94

2.3

2.7

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

321

2949

1.11

0.93

2.6

2.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

1.72

0.92

5.7

7.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

202

1.39

0.89

1.2

—

(4133840)

2.07

0.89

1.8

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

404

1.27

0.88

1.5

2.0

ug/l

0.7

2.0

0.97

362

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.65

0.88

1.0

1.2

—

(3006653) Thiamine [Moles/volume] in Blood

1.79

0.88

1.2

1.4

nmol/l

145.2

145.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.61

0.87

1.0

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

103

1.56

0.87

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

103

1.56

0.87

1.2

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

103

1.56

0.87

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

103

1.56

0.87

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

103

1.56

0.87

1.2

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

1.58

0.87

1.3

1.4

umol/l

4.9

5.2

0.11

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.72

0.86

1.1

1.2

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

516

4870

1.09

0.86

4.0

3.5

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

170

1.42

0.85

1.3

—

(3052851) Hemolysis interference index of Serum or Plasma

344

1.29

0.85

3.4

3.2

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

112

1.52

0.85

5.5

2.4

e6/l

510.1

615.3

0.47

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

112

1.52

0.85

1.0

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

104

1.54

0.84

1.2

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

274

1.32

0.84

1.5

1.6

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

146

1.44

0.82

1.0

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

138

1.46

0.81

1.5

1.4

mmol/l

9.2

12.2

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

111

963

1.16

0.80

3.6

4.3

ug/l

13.5

13.4

0.00

780

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.79

0.0

1.0

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.82

0.79

1.2

1.5

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

106

1.51

0.79

3.4

1.5

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

106

1.51

0.79

3.4

1.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

106

1.51

0.79

3.4

1.5

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.67

0.78

1.0

1.2

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

512

1.22

0.77

1.6

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

1.52

0.75

1.7

1.4

nmol/l

1.5

1.4

0.13

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

218

1.34

0.75

1.8

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

613

0.81

0.75

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

542

1.21

0.74

1.5

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

2.09

0.74

1.2

1.6

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.09

0.74

1.2

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

506

1.21

0.74

6.2

4.3

0.7

0.04

486

(1761482) Bacteria [#/volume] in Urine by Culture

254

1.31

0.73

3.5

4.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

108

1.49

0.73

5.6

2.4

e9/l

0.3

0.2

0.61

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

433

4084

1.08

0.73

3.3

3.2

ng/l

29.9

37.0

0.43

246

2493

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.61

0.72

4.9

1.5

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.61

0.72

4.9

1.5

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.61

0.72

1.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.61

0.72

4.9

1.5

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.61

0.72

4.9

1.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

134

1.42

0.71

1.6

1.3

u/ml

0.7

4.0

1.14

(4268621)

151

1.40

0.71

2.8

2.3

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

1.75

0.71

1.9

2.5

—

(3017704) Immunofixation for Urine

1.58

0.71

1.3

1.6

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

1.71

0.70

1.6

2.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.55

0.69

1.0

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

301

1.27

0.69

1.4

1.2

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

453

0.79

0.69

1.5

—

(3009871) Measles virus Ab [Titer] in Serum

1.67

0.68

1.1

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

240

1.30

0.67

1.1

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

440

0.79

0.67

1.3

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

153

1.38

0.67

1.0

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.79

0.66

1.2

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

241

1.29

0.66

1.2

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

1.52

0.66

1.5

1.6

22.4

33.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.54

0.65

1.1

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.54

0.65

2.0

1.8

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.54

0.65

1.1

1.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.59

0.65

1.7

1.5

—

(3019225) pH of Specimen

1082

0.87

0.64

5.1

3.9

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

496

1.20

0.64

1.7

1.5

u/l

9.1

8.8

0.06

395

(3008152) Bicarbonate [Moles/volume] in Arterial blood

635

1.17

0.64

6.1

8.6

mmol/l

24.6

24.5

0.04

592

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

163

1.35

0.64

1.3

1.1

84.7

95.6

1.06

153

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

129

1.40

0.63

1.8

70.2

60.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

261

1.27

0.62

2.8

3.5

mg/l

17.8

23.7

0.59

165

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.52

0.62

1.0

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

279

1.26

0.62

1.8

1.3

—

(4146454)

101

0.59

0.62

2.8

3.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.67

0.61

3.2

2.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

182

1.32

0.61

2.7

2.5

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

371

1.22

0.60

3.0

2.0

iu/l

6.3

5.2

0.18

139

(3000570) Elastase.pancreatic [Mass/mass] in Stool

353

1.22

0.60

1.5

1.4

ug/g

293.3

309.9

0.16

194

(3024471) HLA-A [Type]

1.57

0.60

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

0.00

0.60

0.0

9.7

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.60

0.0

1.0

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

105

1.43

0.60

1.2

1.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.54

0.59

2.1

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.54

0.59

2.1

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.54

0.59

1.0

1.2

—

(3032057) Clostridioides difficile [Presence] in Stool

0.00

0.59

0.0

1.9

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

418

1.20

0.59

1.1

u/ml

5.9

5.6

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.45

0.59

1.1

1.5

—

(3005033) Fetal Nuchal fold Thickness US

453

0.81

0.58

1.5

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

140

1.36

0.58

6.9

4.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.58

0.0

1.9

—

7.5

—

(3044941) Cell count panel - Synovial fluid

175

1.32

0.58

1.6

1.5

—

(3025941) Bacteria identified in Stool by Culture

764

1.15

0.58

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

202

1.29

0.57

1.2

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

264

2467

1.08

0.57

2.5

2.3

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

167

1.32

0.57

1.5

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.62

0.55

1.0

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.62

0.55

1.0

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

159

1.33

0.55

1.6

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

107

1.41

0.55

1.5

1.4

—

(3020891) Body temperature

413

1.19

0.54

4.5

5.1

—

(4281824)

126

0.63

0.54

1.0

1.2

—

(3049717) Cytology report of Urine Cyto stain

361

0.80

0.54

2.9

2.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

134

1.35

0.53

1.6

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.45

0.53

1.8

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.45

0.53

1.8

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

143

1.33

0.52

1.3

u/ml

3.8

15.2

—

(1002224) Polysomnography panel

564

1.16

0.52

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

147

1344

1.10

0.52

8.2

6.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

155

1422

1.10

0.51

2.5

2.8

ug/l

0.6

0.7

0.99

880

(3042631) Mycobacterium sp identified in Specimen

126

1.35

0.51

3.1

3.4

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

1.50

0.51

2.2

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.50

0.51

1.0

1.2

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.50

0.51

3.0

2.3

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.39

0.50

1.2

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.39

0.50

1.1

miu/ml

1663.2

1543.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

288

1.22

0.50

1.4

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

1.47

0.50

1.3

2.3

umol/l

23.6

16.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

465

0.83

0.49

1.5

—

(4306422)

207

1.26

0.49

1.4

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

511

1.16

0.49

1.6

1.4

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

1.56

0.49

1.7

1.4

—

1.9

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.56

0.49

1.1

1.4

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

308

1.21

0.48

3.5

5.1

u/ml

0.4

0.05

174

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

336

3192

1.07

0.48

1.8

1.7

mmol/l

1.4

0.19

292

2730

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

240

2253

1.08

0.48

2.3

2.1

—

(3029075) Extractable nuclear Ab panel - Serum

1.46

0.46

1.1

1.0

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.39

0.46

4.9

3.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

250

2356

1.07

0.45

1.6

pmol/l

85454980.8

29320329.7

0.49

220

1985

(3024932) HLA-DR beta [Type]

1.40

0.45

1.3

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

1.40

0.45

1.9

2.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

101

915

1.11

0.44

2.3

2.5

ml/min/173m2

64.0

71.7

0.82

355

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1091

0.90

0.44

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

296

0.81

0.43

1.2

1.1

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

275

1.20

0.43

3.6

3.7

e9/l

4.3

4.1

0.24

275

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

142

1312

1.09

0.43

1.5

1.6

—

(3029937) Albumin [Presence] in Urine by Test strip

355

3393

1.06

0.42

4.3

3.7

estimate

0.0

0.10

125

1217

(3051651) Icteric interference index of Serum or Plasma

0.66

0.42

7.0

3.6

—

(3035933) Granulocytes/100 leukocytes in Blood

0.65

0.42

1.0

1.8

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.56

0.42

1.2

1.3

—

(3003740) Influenza virus B Ag [Presence] in Specimen

294

0.81

0.41

1.2

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

126

1160

1.09

0.41

3.2

2.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.36

0.41

2.1

2.3

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.41

0.0

1.1

—

(3019174) dRVVT (LA screen)

0.00

0.41

0.0

1.2

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.41

0.0

3.1

—

0.7

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

0.00

0.41

0.0

1.7

—

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

0.00

0.41

0.0

3.7

—

7.5

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.41

0.0

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.41

0.0

1.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

0.00

0.41

0.0

3.7

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.36

0.41

1.0

1.3

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.47

0.40

1.4

ug/l

7.5

8.7

—

(40768446) Kidney Pathology biopsy report

1.34

0.40

1.0

1.9

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

159

1.26

0.40

2.1

1.6

mmol/l

7.8

7.4

0.32

(4034850)

378

0.84

0.39

11.9

9.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

106

1.32

0.39

1.0

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

115

1.31

0.39

1.0

1.5

umol/l

7.4

11.1

4.26

109

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

391

1.16

0.39

1.8

1.9

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.35

0.38

1.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

205

1935

1.07

0.37

1.5

—

(4094501)

271

1.18

0.37

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

107

1.31

0.37

1.0

1.2

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.35

0.37

1.0

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.35

0.37

1.0

1.2

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

262

1.19

0.37

2.3

2.7

umol/l

4.5

7.4

1.43

192

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

134

1.27

0.37

4.5

4.3

u/ml

12.8

70.6

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.39

0.37

1.7

1.6

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

281

1.18

0.36

4.2

3.9

57.5

56.6

0.18

281

(3015183) Erythrocyte sedimentation rate

1.36

0.36

1.4

1.2

—

(3012441) Differential panel - Pleural fluid

0.62

0.35

1.2

1.4

—

(3004451) EKG impression Narrative

1.40

0.35

1.0

1.3

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

264

1.18

0.34

1.3

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

163

1.23

0.34

2.3

1.4

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

294

1.16

0.32

1.2

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

483

1.12

0.32

1.8

1.7

—

(3017569) Oxygen content in Arterial blood

1.28

0.32

1.0

3.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

183

1.21

0.32

1.6

1.5

—

(3027944) Amphetamines [Presence] in Urine

839

1.09

0.31

1.7

2.1

—

(3008898) HLA-B27 [Presence]

559

0.89

0.31

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.32

0.31

1.6

3.3

—

(3028433) Virus identified in Specimen by Culture

1.30

0.30

1.0

1.3

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

120

1.25

0.30

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

120

1.25

0.30

2.0

2.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

120

1.25

0.30

1.0

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

325

1.14

0.29

1.3

1.5

pmol/l

82.6

170.9

0.97

318

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.25

0.29

2.4

4.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

316

1.14

0.29

1.3

1.2

u/ml

1.9

12.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

251

1.16

0.28

2.6

2.3

g/l

130.8

131.4

0.05

191

(3004716) Salmonella sp identified in Stool by Organism specific culture

864

1.08

0.28

1.3

1.4

—

(3021788) Differential panel - Synovial fluid

195

1.18

0.28

1.6

1.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

195

1.18

0.28

1.9

1.4

mmol/l

7.2

0.00

132

(3016879) Cocaine [Presence] in Urine

787

1.08

0.28

1.7

2.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

205

1.17

0.27

2.6

2.8

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

1.23

0.27

1.3

1.2

u/ml

—

8.3

—

(3011648) Oxygen content in Venous blood

113

1.24

0.26

19.0

8.0

10.3

11.1

0.28

113

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.20

0.26

2.1

2.4

ug/l

22.2

139.9

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

214

0.84

0.26

2.0

4.2

u/ml

23.3

28.8

0.20

208

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

530

0.90

0.26

1.4

1.6

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

434

1.11

0.26

1.4

1.6

iu/ml

0.2

—

(3000330) Specific gravity of Urine by Test strip

559

1.09

0.25

3.1

3.0

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

160

1.19

0.25

2.4

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

123

1.22

0.25

2.0

2.2

mg/l

19.0

30.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

123

1.22

0.25

1.1

—

(3021901) Oxygen saturation in Capillary blood

207

1.16

0.25

3.5

3.7

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.20

0.25

1.0

—

(3028300) Cannabinoids [Presence] in Urine

853

1.07

0.23

1.7

2.1

—

(21494755) Public health laboratory ask at order entry panel

140

1471

0.95

0.23

1.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.32

0.23

1.0

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.32

0.23

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

106

1.23

0.23

1.2

—

(3028707) Methadone [Presence] in Urine by Screen method

390

0.90

0.23

2.5

2.9

—

(3037121) Protein [Mass/volume] in Urine

457

1.10

0.23

3.7

4.5

g/l

0.3

0.27

219

(3024522) Salmonella sp identified in Specimen by Organism specific culture

162

1.17

0.23

2.4

1.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.74

0.22

1.6

1.4

—

(3000764) Benzodiazepines [Presence] in Urine

846

1.07

0.22

1.7

2.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

107

1.22

0.21

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

0.00

0.21

0.0

1.0

—

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

3.5

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.21

0.0

1.4

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.0

—

18.3

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.21

0.0

3.4

—

4.5

—

(3007463) Buprenorphine [Presence] in Urine

0.00

0.21

0.0

2.4

—

(3014891) Appearance of Pleural fluid

0.00

0.21

0.0

1.5

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

105

0.76

0.21

1.0

1.2

—

250.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

0.00

0.21

0.0

1.0

—

2.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.21

0.0

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

470

1.09

0.20

5.0

4.0

53.8

50.2

0.48

462

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

0.00

0.20

0.0

1.7

—

7.3

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

0.00

0.20

0.0

1.7

—

2.4

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

0.00

0.20

0.0

1.7

—

3.5

—

(3044927) Protein electrophoresis panel - Urine

111

0.81

0.20

1.1

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

384

1.10

0.20

2.5

1.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

346

1.10

0.19

1.6

1.5

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

137

1.17

0.18

1.2

2.1

—

(3045414) Leukocytes [Presence] in Urine

560

1.07

0.18

1.4

1.7

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

600

1.07

0.18

2.0

1.9

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.17

0.17

1.0

1.1

—

(3045424) Erythrocytes [Presence] in Urine

205

0.88

0.17

1.1

1.4

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

224

1.12

0.17

2.1

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

215

1.12

0.16

4.0

5.8

umol/l

375.6

385.4

0.11

193

(3003694) ABO and Rh group [Type] in Blood

405

3972

1.03

0.16

1.5

1.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

196

1.12

0.16

1.5

1.7

—

1506.7

—

(3023419) Bacteria identified in Sputum by Culture

139

1.15

0.16

1.8

3.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

183

0.87

0.16

1.1

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1.13

0.16

3.5

6.4

—

70.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.20

0.16

1.5

1.6

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

235

1.11

0.15

1.0

1.1

u/ml

6.1

3.3

—

106

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.15

0.15

1.2

1.1

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.14

0.15

1.4

1.2

—

(3027008) Opiates [Presence] in Urine

850

1.05

0.15

1.7

2.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1.18

0.14

1.4

1.3

nmol/l

24.1

32.9

0.56

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

131

1.15

0.14

1.2

1.1

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

930

1.05

0.14

1.3

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

208

1.11

0.14

1.7

1.4

—

(4024509)

0.81

0.13

1.1

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

199

1.11

0.13

3.9

3.0

mmol/l

8.3

7.3

1.13

194

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

113

1.15

0.13

1.5

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

1.17

0.13

1.0

1.6

umol/l

29.6

25.3

0.16

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

903

1.04

0.13

5.7

6.2

mmol/l

1.4

0.01

660

(3018405) Lactate [Moles/volume] in Arterial blood

374

1.07

0.13

4.1

4.2

mmol/l

1.4

1.3

0.17

366

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

433

1.06

0.12

3.3

1.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

581

1.05

0.12

1.3

1.7

mg/l

5.8

4.4

0.22

391

(3038177) Helicobacter pylori Ab [Presence] in Serum

230

1.09

0.11

1.1

1.2

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

1.16

0.11

1.3

1.1

—

1.8

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.14

0.10

7.4

1.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.14

0.10

7.4

1.6

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.11

0.09

7.4

1.6

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.09

0.09

2.8

3.1

—

(3017732) Neutrophils [#/volume] in Blood

889

0.97

0.09

2.3

2.5

e9/l

4.2

4.1

0.07

732

(3047189) Immunofixation for 24 hour Urine

1.06

0.09

1.2

1.8

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

237

0.93

0.09

1.5

1.8

—

4.6

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.07

0.08

1.5

2.1

—

252.4

—

(1617658) Protocol used for examination of sentinel lymph nodes

107

1.12

0.08

1.2

1.1

—

(40768800) Prostate Pathology biopsy report

144

0.90

0.08

1.1

1.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.03

0.07

1.0

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

358

3542

1.01

0.07

3.2

3.0

—

(3009343) pH of Capillary blood

927

1.03

0.07

5.6

6.2

7.4

1.21

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.03

0.07

1.2

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.02

0.07

1.3

2.5

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

680

1.03

0.06

1.8

2.2

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

101

0.89

0.06

7.2

14.4

nmol/l

795.4

797.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

105

0.86

0.06

4.2

1.8

—

(40768793) Breast Pathology biopsy report

306

1.05

0.05

1.3

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.11

0.05

1.1

1.5

—

(44813793)

110

1.09

0.05

1.1

—

(3005570) Glucose [Moles/volume] in Urine

130

0.92

0.04

1.4

2.3

—

(40761536) Microorganisms panel - Urine sediment

116

1142

1.02

0.04

4.2

3.6

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

1.10

0.04

1.4

1.1

—

69.1

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

1.10

0.04

1.4

1.1

—

38.2

—

(3022313) Gas panel - Capillary blood

724

0.98

0.04

6.0

6.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

936

1.02

0.03

5.7

6.2

kpa

5.2

5.1

0.31

887

(3025468) Yersinia sp identified in Specimen by Organism specific culture

161

1.06

0.03

2.5

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

161

1.06

0.03

2.5

1.4

—

(3014051) Protein [Presence] in Urine by Test strip

290

1.04

0.03

1.8

1.9

—

(3013512) EKG study

307

3088

0.99

0.03

3.2

3.4

—

(3004616) Nuclear Ab [Presence] in Serum

142

1.06

0.02

1.7

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

162

1.05

0.02

2.5

1.4

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

431

1.02

0.02

1.5

—

(3038026) Centromere Ab [Units/volume] in Serum

1.08

0.02

1.4

1.1

—

73.0

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

137

0.95

0.01

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

598

0.99

0.01

2.5

3.0

—

(3050129) First trimester maternal screen panel - Serum or Plasma

692

1.01

0.01

1.5

1.4

—

(3001019) Free T4 and TSH panel - Serum or Plasma

827

0.99

0.01

1.8

1.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

116

0.95

0.00

1.1

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.04

0.00

2.0

2.3

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.04

0.00

2.2

1.6

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

144

0.97

0.00

1.7

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

214

0.98

0.00

2.5

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

148

1.01

0.00

1.4

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

168

1.01

0.00

1.6

1.5

—

(3008037) Lactate [Moles/volume] in Venous blood

218

1.01

0.00

3.9

2.8

mmol/l

1.8

1.5

1.43

212

(3022621) pH of Urine by Test strip

802

1.00

0.00

2.5

2.7

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

241

1.00

0.00

4.6

2.4

ug/min

96.9

113.0

0.07

151

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.03

0.00

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.05

0.00

2.7

2.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

2.2

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

2.2

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3016750) Collection duration of Urine

0.92

0.00

7.7

2.2

min

527.5

497.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.01

0.00

1.6

1.2

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

0.94

0.00

1.2

u/ml

1.3

4.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

0.94

0.00

1.2

1.3

u/l

102.3

398.5

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3026726) Creatinine [Moles/volume] in Specimen

0.00

0.0

2.5

—

315.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3013762) Body weight Measured

0.00

0.0

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

120

1.00

0.00

5.6

3.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.91

0.00

1.6

1.7

—

(3025315) Body weight

0.00

0.0

1.9

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

328.0

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

6.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3009410) PHENobarbital [Moles/volume] in Serum or Plasma

0.00

0.0

8.9

—

89.9

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.2

—

(40768441) Liver Pathology biopsy report

0.93

0.00

1.0

1.5

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.0

2.1

—

(4198724)

0.98

0.00

1.9

1.7

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.0

1.0

—

(40768806) Pleura Pathology biopsy report

0.93

0.00

1.3

1.5

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.1

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(3004959) Base excess in Arterial cord blood by calculation

0.97

0.00

1.0

—

0.7

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3006598) pH of Arterial cord blood

0.97

0.00

1.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

0.92

0.00

1.0

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint Q17_OTHER_CONGEN_MALFO_SKIN and mortality.

Females

Parameter	HR [95% CI]	p-value
Q17_OTHER_CONGEN_MALFO_SKIN	1.014 [0.88, 1.17]	0.843
Birth year	1.0 [0.99, 1.01]	0.907

During the follow-up period (1.1.1998 — 31.12.2019), 482 out of 9147 females with Q17_OTHER_CONGEN_MALFO_SKIN died.

Males

Parameter	HR [95% CI]	p-value
Q17_OTHER_CONGEN_MALFO_SKIN	1.033 [0.9, 1.18]	0.638
Birth year	0.989 [0.98, 1.0]	0.024

During the follow-up period (1.1.1998 — 31.12.2019), 444 out of 6458 males with Q17_OTHER_CONGEN_MALFO_SKIN died.

Mortality risk

Mortality risk for people of age

years, who have Q17_OTHER_CONGEN_MALFO_SKIN.

N-year risk	Females	Males
1	0.131%	0.204%
5	0.653%	1.158%
10	1.623%	3.183%
15	3.116%	6.268%
20	5.536%	10.467%

Relationships between endpoints

↥

Index endpoint: Q17_OTHER_CONGEN_MALFO_SKIN – Other congenital malformations of skin

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Other congenital malformations of skin

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints